Custom service
Peptide Sulfation
Sulfate tyr residues for proteins such as ccr ligands and coagulation peptides
Peptide Sulfation supports programmes that sulfate Tyr residues for proteins such as CCR ligands and coagulation peptides. In a typical engagement we plan the Tyr-sulfation during synthesis route first, confirm compatibility with sulfate-labile protecting strategy, and release sulfated peptide with site-selectivity data on a 3–5 weeks schedule.
Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep Tyr-sulfation during synthesis as the primary option and hold sulfate-labile protecting strategy in reserve, so that scale-up never depends on an unproven step.
Chemokine-receptor ligand studies
Hirudin-class coagulation peptides
Multi-site sulfation where positional isomers are not separable
Modifications requiring radiological or BSL-3 containment
Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.
Service Highlights
- Tyr-sulfation during synthesis as the default route, with sulfate-labile protecting strategy held as a proven fallback
- Sulfation-site isomer control worked into the design where the application requires it
- Modification sites are mapped on the sequence and confirmed by MS/MS before release
- Analytical confirmation of every intermediate before the final release
- Modified and unmodified species are separated and quantified, not just reported
- Sulfated peptide with site-selectivity data delivered with a complete conjugation or synthesis certificate
How the work runs
Sequence & modification map
We annotate every modification site, protection strategy and analytical target before synthesis starts.
Solid-phase assembly
The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.
Modification chemistry
Post-synthesis steps — Tyr-sulfation during synthesis, sulfate-labile protecting strategy — are run under conditions validated on a test cleavage.
Cleavage & purification
Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.
Analytical release
Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.
Documentation
Sulfated peptide with site-selectivity data is released with the batch record and analytical package after QC sign-off.
Specifications & timeline
- Turnaround
- 3–5 weeks
- Typical scale
- 0.5 mg – 1 g modified peptide
- Chemistry options
- Tyr-sulfation during synthesis; sulfate-labile protecting strategy; sulfation-site isomer control
- Deliverable
- Sulfated peptide with site-selectivity data
- QC package
- HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
- Shipping
- Ambient or blue ice as stability data dictate
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.